RPg Family Wealth Advisory’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,900
| Closed | -$34.2K | – | 118 |
|
|
2022
Q1 | $34.2K | Hold |
1,900
| – | – | 0.01% | 177 |
|
|
2021
Q4 | $45.2K | Hold |
1,900
| – | – | 0.02% | 169 |
|
|
2021
Q3 | $57.7K | Hold |
1,900
| – | – | 0.02% | 160 |
|
|
2021
Q2 | $60.6K | Buy |
+1,900
| New | +$60.6K | 0.02% | 163 |
|
|
2020
Q4 | $60.8K | Sell |
1,900
-700
| -27% | -$22.4K | 0.03% | 154 |
|
|
2020
Q3 | $71.4K | Sell |
2,600
-450
| -15% | -$12.4K | 0.04% | 147 |
|
|
2020
Q2 | $82.6K | Sell |
3,050
-1,150
| -27% | -$31.2K | 0.05% | 142 |
|
|
2020
Q1 | $82K | Buy |
4,200
+1,250
| +42% | +$24.4K | 0.06% | 114 |
|
|
2019
Q4 | $69.1K | Sell |
2,950
-1,341
| -31% | -$31.4K | 0.04% | 140 |
|
|
2019
Q3 | $80.5K | Sell |
4,291
-880
| -17% | -$16.5K | 0.05% | 126 |
|
|
2019
Q2 | $109K | Hold |
5,171
| – | – | 0.06% | 112 |
|
|
2019
Q1 | $109K | Buy |
5,171
+1,250
| +32% | +$26.3K | 0.06% | 113 |
|
|
2018
Q4 | $74K | Sell |
3,921
-1,100
| -22% | -$20.8K | 0.07% | 87 |
|
|
2018
Q3 | $125K | Buy |
5,021
+2,280
| +83% | +$56.6K | 0.09% | 73 |
|
|
2018
Q2 | $66.2K | Buy |
+2,741
| New | +$66.2K | 0.05% | 102 |
|